FINNISH STUDY CITED AS SUPPORTING FDA's POSITION ON ANTIOXIDANT SUPPLEMENTS
This article was originally published in The Tan Sheet
Executive Summary
FINNISH STUDY CITED AS SUPPORTING FDA's POSITION ON ANTIOXIDANT SUPPLEMENTS and their potential role in lowering cancer risk by Center for Food Safety & Applied Nutrition Office of Special Nutritionals Acting Director Elizabeth Yetley, PhD, at a May 9 meeting of FDA's Food Advisory Committee, Yetley said the findings of the Alpha-Tocopherol, Beta Carotene (ATBC) Cancer Prevention Study are "consistent with the health claim we now have on the books, and that is that diets rich in fruits and vegetables are associated with reduced risks of cancer."
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning